CIBC Private Wealth Group’s Twist Bioscience TWST Stock Holding History

CIBC Private Wealth Group’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$572K	Buy	18,028 +1	+0%	+$31	﹤0.01%	844
2025 Q3	$507K	Sell	18,027 -1	-0%	-$30	﹤0.01%	858
2025 Q2	$663K	Buy	18,028 +1	+0%	+$35	﹤0.01%	761
2025 Q1	$634K	Sell	18,027 -2,000	-10%	-$90.1K	﹤0.01%	745
2024 Q4	$904K	Hold	20,027	–	–	﹤0.01%	714
2024 Q3	$905K	Sell	20,027 -10	-0%	-$476	﹤0.01%	710
2024 Q2	$981K	Sell	20,037 -1,010	-5%	-$41.2K	﹤0.01%	667
2024 Q1	$724K	Buy	21,047 +1,020	+5%	+$36.8K	﹤0.01%	745
2023 Q4	$738K	Hold	20,027	–	–	﹤0.01%	709
2023 Q3	$406K	Buy	20,027 +27	+0.1%	+$593	﹤0.01%	805
2023 Q2	$409K	Hold	20,000	–	–	﹤0.01%	727
2023 Q1	$302K	Hold	20,000	–	–	﹤0.01%	782
2022 Q4	$476	Hold	20,000	–	–	﹤0.01%	796
2022 Q3	$705K	Hold	20,000	–	–	﹤0.01%	650
2022 Q2	$699K	Buy	20,000 +19,982	+111,011%	+$708K	﹤0.01%	655
2022 Q1	$1K	Buy	+18	New	+$998	﹤0.01%	1250

Other funds holding TWST

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $13.2B AUM 32.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

CIBC Private Wealth Group's TWST Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Twist Bioscience (TWST) stake by 0.01% in Q4 2025, buying an estimated $31 and bringing the position to 18,028 shares worth $572K. The position accounts for ﹤0.01% of the portfolio, ranked #844.

CIBC Private Wealth Group first reported a position in TWST in Q1 2022 and has held it in 16 quarters since. The position peaked at $981K in Q2 2024. 244 funds tracked by Wall St. Rank hold TWST as of Q4 2025.

CIBC Private Wealth Group held 18,028 shares of Twist Bioscience worth $572K as of Q4 2025.
CIBC Private Wealth Group bought 1 Twist Bioscience share in Q4 2025, an estimated $31.
Twist Bioscience made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #844 holding.
CIBC Private Wealth Group first reported a position in Twist Bioscience in Q1 2022 and has held it in 16 quarters since.
CIBC Private Wealth Group's Twist Bioscience position peaked at $981K in Q2 2024.
244 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.